Oxford University Press

SHERPA: Yellow

People

  1. Drilon
    Drilon
  2. Motzer
    Motzer
  3. Mellinghoff
    Mellinghoff
  4. Shuman
    Shuman
  5. Rosenblum
    Rosenblum
  6. Dunkel
    Dunkel
  7. Karajannis
    Karajannis
  8. Saltz
    Saltz
  9. Souweidane
    Souweidane
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (1996)
  2. Solid Tumor Oncology Division (1625)
  3. GSK Faculty (766)
  4. Survivorship Research (640)
  5. Population Sciences Research Program (616)
  6. Epidemiology and Biostatistics (466)
  7. Department of Pathology and Laboratory Medicine (416)
  8. Gastrointestinal Oncology Service (387)
  9. Genitourinary Oncology Service (367)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2131)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (92)
  5. Editorial (84)
  6. Guidelines (36)
  7. Correspondence (26)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (10)
Groups
  1. Department of Medicine (1996)
  2. Solid Tumor Oncology Division (1625)
  3. GSK Faculty (766)
  4. Survivorship Research (640)
  5. Population Sciences Research Program (616)
  6. Epidemiology and Biostatistics (466)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Stewart Shuman (88)
  6. Marc Rosenblum (87)

More People

Years
  1. 2025 (129)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1670)
  2. Neuro-Oncology (855)
  3. JNCI: Journal of the National Cancer Institute (492)
  4. Nucleic Acids Research (210)
  5. Clinical Infectious Diseases (140)
  6. American Journal of Clinical Pathology (106)

More Publications

Results (4676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S.; Smith-Marrone, S.; Mueller, B.; Ng, K. K.; Dutta, P. R.; Gelblum, D. Y.; Lee, J. L.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
    Journal Article

    Baselga, J.; Manikhas, A.; Cortés, J.; Llombart, A.; Roman, L.; Semiglazov, V. F.; Byakhov, M.; Lokanatha, D.; Forenza, S.; Goldfarb, R. H.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer
    Journal Article

    Arnedos, M.; Drury, S.; Afentakis, M.; A'Hern, R.; Hills, M.; Salter, J.; Smith, I. E.; Reis-Filho, J. S.; Dowsett, M.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing
    Journal Article

    Yu, H. A.; Arcila, M. E.; Hellmann, M. D.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: A pooled analysis in the ovarian cancer association consortium
    Journal Article

    Trabert, B.; Ness, R. B.; Lo-Ciganic, W. H.; Murphy, M. A.; Goode, E. L.; Poole, E. M.; Brinton, L. A.; Webb, P. M.; Nagle, C. M.; Jordan, S. J.; more...
    JNCI: Journal of the National Cancer Institute (2014)

    Fulltext@MSK | Save
  • REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
    Journal Article

    Svensson, C.; Ceder, J.; Iglesias-Gato, D.; Chuan, Y. C.; Pang, S. T.; Bjartell, A.; Martinez, R. M.; Bott, L.; Helczynski, L.; Ulmert, D.; more...
    Nucleic Acids Research (2014)

    Fulltext@MSK | Save
  • Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: Results from the phase III AFFIRM trial
    Journal Article

    Sternberg, C. N.; de Bono, J. S.; Chi, K. N.; Fizazi, K.; Mulders, P.; Cerbone, L.; Hirmand, M.; Forer, D.; Scher, H. I.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC
    Journal Article

    Ou, S. H. I.; Jänne, P. A.; Bartlett, C. H.; Tang, Y.; Kim, D. W.; Otterson, G. A.; Crinò, L.; Selaru, P.; Cohen, D. P.; Clark, J. W.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas
    Journal Article

    Karajannis, M. A.; Legault, G.; Hagiwara, M.; Giancotti, F. G.; Filatov, A.; Derman, A.; Hochman, T.; Goldberg, J. D.; Vega, E.; Wisoff, J. H.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Where are we now? and where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) Low-grade Glioma Research Workshop
    Journal Article

    Huse, J. T.; Wallace, M.; Aldape, K. D.; Berger, M. S.; Bettegowda, C.; Brat, D. J.; Cahill, D. P.; Cloughesy, T.; Haas-Kogan, D. A.; Marra, M.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save